# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA361184 | 5 | Ratio | = | 0.85 | ALA2444336 | Mus musculus | |||||
2. | ALA2440363 | (S)-7 | EC50 | = | 0.9 | nM | ALA2444337 | 9.05 | nM | Mus musculus | ||
3. | ALA180886 | 3 | Ratio | = | 1.1 | ALA2444336 | Mus musculus | |||||
4. | (S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide | (S)-1 | Ratio | = | 1.4 | ALA2444336 | Mus musculus | |||||
5. | Retigabine | 1 (Retigabine) | Ratio | = | 1.6 | ALA2444336 | Mus musculus | |||||
6. | ALA176931 | (S)-2 | Ratio | = | 1.8 | ALA2444336 | Mus musculus | |||||
7. | ALA401942 | table 1, R5C1 | Ratio | = | 2.2 | ALA2444336 | Mus musculus | |||||
8. | ALA401942 | table 1, R5C1 | EC50 | = | 2.4 | nM | ALA2444337 | 8.62 | nM | Mus musculus | ||
9. | ALA2440363 | (S)-7 | Ratio | = | 2.9 | ALA2444336 | Mus musculus | |||||
10. | ALA361184 | 5 | EC50 | = | 10 | nM | ALA2444337 | 8.00 | nM | Mus musculus | ||
11. | ALA180886 | 3 | EC50 | = | 20 | nM | ALA2444337 | 7.70 | nM | Mus musculus | ||
12. | ALA401942 | table 1, R5C1 | Efficacy | = | 38 | % | ALA2444335 | % | Mus musculus | |||
13. | ALA176931 | (S)-2 | EC50 | = | 60 | nM | ALA2444337 | 7.22 | nM | Mus musculus | ||
14. | Retigabine | 1 (Retigabine) | EC50 | = | 1300 | nM | ALA2444337 | 5.89 | nM | Mus musculus | ||
15. | (S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide | (S)-1 | EC50 | = | 3200 | nM | ALA2444337 | 5.50 | nM | Mus musculus | ||
16. | ALA2440362 | (R)-6 | EC50 | > | 10000 | nM | ALA2444337 | nM | Mus musculus | |||
17. | ALA2440364 | (R)-7 | EC50 | > | 10000 | nM | ALA2444337 | nM | Mus musculus | |||
18. | Retigabine | 1 (Retigabine) | E/Eref | = | 1.6 | ALA836871 | Mus musculus | |||||
19. | Retigabine | 1 (Retigabine) | EC50 | = | 1.3 | uM | ALA838011 | 5.89 | nM | Mus musculus | ||
20. | ALA183545 | 10 | E/Eref | = | 1.9 | ALA836871 | Mus musculus |